Home » Topics » BioWorld Science

BioWorld Science
RSS

Novel sertraline composition for mood disorders

May 3, 1996

Asahi discloses anxiolytic/cognition-enhancing drugs

May 3, 1996

NDA filing for ViaScint

May 3, 1996

ProstaScint up for advisory committee review

May 3, 1996

Abbott outlines hepatitis diagnostic research

May 3, 1996

FDA approves Biomerica's thyroid disease test

May 3, 1996

Novopharm Biotech, BreasTek to codevelop breast cancer monitoring test

May 3, 1996

DynaGen's lobeline transdermal system receives patent coverage

May 3, 1996

Progenitor delves into leptin receptor research

May 3, 1996

Redux cleared for marketing in U.S.

May 3, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 7, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for July 7, 2025.
House passes H.R. 1, restoring R&D tax cuts
BioWorld MedTech
The House of Representatives passed H.R. 1, also known as One Big Beautiful Bill, which will restore personal income tax cuts that expired in 2022. However, the...
With surface mimicry, molecular glues shed hairpin need
BioWorld Science
Degradation is a therapeutic strategy that could offer possibilities to get at currently undruggable target proteins. In targeted degradation, compounds induce...
Exercise-mimicking compound offers alternative to GLP-1 therapies
BioWorld
An experimental drug for treating diabetes and obesity has been shown to lower blood sugar levels and increase fat burning. It is a β2-adrenergic receptor (β2AR)...